Calcium channel blockers for primary Raynaud's phenomenon

Author:

Ennis Holly1,Hughes Michael2,Anderson Marina E3,Wilkinson Jack4,Herrick Ariane L2

Affiliation:

1. University of Edinburgh; Edinburgh Clinical Trials Unit; OPD Building Level 2 Western General Hospital Edinburgh UK EH4 2XU

2. University of Manchester, Manchester Academic Health Science Centre; Centre for Musculoskeletal Research, Institute of Inflammation and Repair; Stopford Building Oxford Road Manchester UK M13 9PT

3. University of Liverpool; Institute of Ageing and Chronic Disease; Liverpool UK

4. University of Manchester, Manchester Academic Health Science Centre; Biostatistics, Institute of Population Health; Clinical Sciences Building Salford Royal NHS Foundation Trust Hospital Stott Lane, Salford Manchester UK M6 8HD

Publisher

Wiley

Subject

Pharmacology (medical)

Reference117 articles.

1. Controlled double-blind trial of dazoxiben and nifedipine in the treatment of Raynaud's phenomenon;Ettinger;American Journal of Medicine,1984

2. Nifedipine in the treatment of Raynaud's phenomenon. Evidence for inhibition of platelet activation;Malamet;American Journal of Medicine,1985

3. Reproducibility of cold provocation in patients with Raynaud's phenomenon;Wigley;Journal of Rheumatology,1987

4. Nicardipine in the treatment of Raynaud's phenomenon;Kahan;Revue du Rhumatisme et des Maladies Osteo-Articulaires,1987

5. Nicardipine in the treatment of Raynaud's phenomenon: A randomized double-blind trial;Kahan;Angiology,1987

Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3